| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |